Searched for
SENTYNL THERAPEUTICS
Stocks in news: RBL Bank, Hyundai India, SBI, Zydus Life, DelhiveryMarkets ended nearly unchanged amid volatility, with rupee weakness and mixed global cues dictating direction. Rotational strength in heavy...- Stocks in news: YES Bank, Godrej Consumer, Kotak Bank, IDBI Bank, DMartShares of Godrej Consumer, Lupin, Indian Bank, and Marico will be in focus today as the companies will announce their quarterly results.
- Zydus Lifesciences Q4 Results: Consolidated net profit dips 25% to Rs 297 croreZydus Lifesciences Ltd reported a 25.36% decline in consolidated net profit at Rs 296.6 crore in the fourth quarter ended March 31, 2023 im...
- Stocks in the news: TCS, Adani Ports, NMDC, Dish TV, IOC and Sun PharmaThe Rs 18,000 crore share buyback of TCS will kick off today and the company will continue to accept shares till March 23. It plans to buy ...
- Zydus' US subsidiary acquires speciality drug asset in USUnder the terms of the agreement, Sentynl will acquire global rights to Nulibry and will be responsible for the ongoing development and com...
- Stocks in the news: Nureca, Dr Reddy's Labs, Affle India, Max Financial and HGSIndia’s drug regulator has not cleared the application of Dr Reddy’s Laboratories seeking approval to market the Sputnik V Covid-19 vaccine...
- Domestic pharmaceutical players eye Bharat Serums acquisitionThe two funds together hold a 23% stake and the remainder is with the Daftary family.
- Indian pharma majors weigh bids for Sanofi’s $2 billion European generics businessThe portfolio of acute, chronic and oncology products could fetch a valuation of $1.5-2 bn, making it among the largest outbound transactio...
- Cadila's new MD Sharvil Patel aims to double revenues in 5 yearsWith a doctoral degree from University of Sunderland, Sharvil is the third generation Patel to lead Cadila. The company was founded by his ...
- Pankaj Patel owned Cadila ups its India game with AZ’s brandsAs part of the agreement, AZ will sell the following brands of Bricarex, Bricarex-A, Bricanyl, Xylocard, Ceriviprime, Prostodin, Partocin a...
- Zydus Cadila acquires US-based Sentynl Therapeutics"It gains access to the specialty distribution network and a large prescriber base....This acquisition will also enable the Zydus group to ...
- Cadila set to buy US firm for $171 millionSentynl acquires, develops and commercialises prescription products, according to the company's website. It holds rights for opioid-based d...
Load More
